ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
Apolipoprotein E (<i>APOE</i>) is the major cholesterol carrier in the brain, affecting various normal cellular processes including neuronal growth, repair and remodeling of membranes, synaptogenesis, clearance and degradation of amyloid β (Aβ) and neuroinflammation. In humans, the <i...
Main Authors: | Maria Fe Lanfranco, Christi Anne Ng, G. William Rebeck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6336 |
Similar Items
-
The role of APOE on lipid homeostasis and inflammation in normal brains
by: G. William Rebeck
Published: (2017-08-01) -
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
by: Rosalía Fernández-Calle, et al.
Published: (2022-09-01) -
Endogenous apoE expression modulates HDL3 binding to macrophages
by: Chen-Yi Lin, et al.
Published: (1998-02-01) -
Effects of Nut Consumption on Blood Lipids and Lipoproteins: A Comprehensive Literature Update
by: Marta Guasch-Ferré, et al.
Published: (2023-01-01) -
Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI
by: Patricia G. Yancey, et al.
Published: (2007-05-01)